NRXP: Nrx Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Nrx Pharmaceuticals Inc (NRXP).
$26.61M Market Cap.
NRXP Market Cap. (MRY)
NRXP Shares Outstanding (MRY)
NRXP Assets (MRY)
Total Assets
$3.65M
Total Liabilities
$26.87M
Total Investments
$0
NRXP Income (MRY)
Revenue
$0
Net Income
-$25.13M
Operating Expense
$18.50M
NRXP Cash Flow (MRY)
CF Operations
-$10.64M
CF Investing
$0
CF Financing
$7.49M
NRXP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $3,651,000 (-50.09%) | $7,315,000 (-71.66%) | $25,816,000 (-21.12%) | $32,729,000 (1012.79%) |
Assets Current | $3,302,000 (-52.03%) | $6,884,000 (-73.31%) | $25,795,000 (-21.15%) | $32,714,000 (1016.42%) |
Assets Non-Current | $349,000 (-19.03%) | $431,000 (1952.38%) | $21,000 (40.00%) | $15,000 (37.44%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$23,223,000 (-97.93%) | -$11,733,000 (-258.36%) | $7,409,000 (-64.39%) | $20,806,000 (147.53%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $1,443,000 (-68.60%) | $4,595,000 (-77.09%) | $20,054,000 (-27.35%) | $27,605,000 (1385.33%) |
Accumulated Other Comprehensive Income | $0 (0%) | -$3,000 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,130,000 (-10.84%) | $4,632,000 (123.12%) | $2,076,000 (-43.69%) | $3,687,000 (16.92%) |
Accumulated Retained Earnings (Deficit) | -$278,273,000 (-9.93%) | -$253,147,000 (-13.52%) | -$222,997,000 (-21.69%) | -$183,243,000 (-103.20%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $6,577,000 (-28.21%) | $9,161,000 (-12.96%) | $10,525,000 (1931.85%) | $518,000 (-34.98%) |
Debt Current | $1,566,000 (-82.91%) | $9,161,000 (18.93%) | $7,703,000 (1387.07%) | $518,000 (108.15%) |
Debt Non-Current | $5,011,000 (0%) | $0 (0%) | $2,822,000 (0%) | $0 (0%) |
Total Liabilities | $26,874,000 (41.09%) | $19,048,000 (3.48%) | $18,407,000 (54.38%) | $11,923,000 (-74.48%) |
Liabilities Current | $21,863,000 (14.78%) | $19,048,000 (22.22%) | $15,585,000 (30.71%) | $11,923,000 (-74.17%) |
Liabilities Non-Current | $5,011,000 (0%) | $0 (0%) | $2,822,000 (0%) | $0 (0%) |
NRXP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $13,505,000 (-5.00%) | $14,216,000 (-47.94%) | $27,308,000 (-63.56%) | $74,944,000 (555.33%) |
Research & Development Expense | $6,199,000 (-53.64%) | $13,371,000 (-21.47%) | $17,027,000 (-15.95%) | $20,257,000 (90.65%) |
Operating Expenses | $18,502,000 (-33.53%) | $27,837,000 (-37.21%) | $44,335,000 (-61.71%) | $115,796,000 (125.34%) |
Interest Expense | $230,000 (91.67%) | $120,000 (0%) | $0 (0%) | $18,000 (-67.86%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$25,126,000 (16.66%) | -$30,150,000 (24.16%) | -$39,754,000 (57.28%) | -$93,063,000 (-79.74%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$25,126,000 (16.66%) | -$30,150,000 (24.16%) | -$39,754,000 (57.28%) | -$93,063,000 (-79.74%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $9,000 (0%) | $0 (0%) | $255,822,000 (0%) |
Net Income Common Stock | -$25,126,000 (16.69%) | -$30,159,000 (24.14%) | -$39,754,000 (88.61%) | -$348,885,000 (-573.82%) |
Weighted Average Shares | $10,644,461 (40.50%) | $7,576,176 (15.20%) | $6,576,679 (40.17%) | $4,691,770 (36.90%) |
Weighted Average Shares Diluted | $10,644,461 (40.50%) | $7,576,176 (15.20%) | $6,576,679 (40.17%) | $4,691,770 (36.90%) |
Earning Before Interest & Taxes (EBIT) | -$24,896,000 (17.10%) | -$30,030,000 (24.46%) | -$39,754,000 (57.27%) | -$93,045,000 (-79.90%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$18,502,000 (33.53%) | -$27,837,000 (37.21%) | -$44,335,000 (61.71%) | -$115,796,000 (-125.34%) |
NRXP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$3,000 (70.00%) | -$10,000 (-42.86%) | -$7,000 (-250.00%) |
Net Cash Flow from Financing | $7,485,000 (20.71%) | $6,201,000 (-80.75%) | $32,214,000 (-49.23%) | $63,456,000 (1853.09%) |
Net Cash Flow from Operations | -$10,637,000 (50.88%) | -$21,657,000 (45.52%) | -$39,755,000 (-5.44%) | -$37,703,000 (-1564.59%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,152,000 (79.61%) | -$15,459,000 (-104.73%) | -$7,551,000 (-129.33%) | $25,746,000 (2521.79%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | -$3,000 (70.00%) | -$10,000 (-42.86%) | -$7,000 (-250.00%) |
Issuance (Repayment) of Debt Securities | -$1,496,000 (51.62%) | -$3,092,000 (-132.54%) | $9,502,000 (844.67%) | -$1,276,000 (-305.81%) |
Issuance (Purchase) of Equity Shares | $5,911,000 (-27.22%) | $8,122,000 (-64.24%) | $22,712,000 (-64.91%) | $64,732,000 (2409.97%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $486,000 (25.58%) | $387,000 (-89.33%) | $3,628,000 (-94.11%) | $61,622,000 (8341.37%) |
Depreciation Amortization & Accretion | $5,000 (0.00%) | $5,000 (25.00%) | $4,000 (100.00%) | $2,000 (0.00%) |
NRXP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | 133.10% (-76.78%) | 573.30% (392.80%) | -195.80% (-100.57%) | 34059.90% (5354.82%) |
Return on Average Assets (ROAA) | -585.50% (-201.03%) | -194.50% (-54.98%) | -125.50% (90.10%) | -1267.50% (-31.22%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 220.30% (-59.83%) | 548.40% (-72.57%) | 1999.20% (403.96%) | 396.70% (-61.82%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.93 (19.38%) | -1.16 (37.51%) | -1.85 (23.36%) | -2.41 (85.06%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | -1.15 (65.17%) | -3.29 (-132.46%) | 10.13 (-24.99%) | 13.51 (1001.33%) |
Debt to Equity Ratio (D/E) | -1.16 (28.71%) | -1.62 (-165.34%) | 2.48 (333.51%) | 0.57 (153.70%) |
Earnings Per Share (EPS) | -2.36 (40.70%) | -3.98 (33.67%) | -6 (69.70%) | -19.8 (-31.13%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1 (65.06%) | -2.86 (52.71%) | -6.05 (24.77%) | -8.04 (-1115.89%) |
Book Value Per Share (BVPS) | -2.18 (-40.87%) | -1.55 (-237.44%) | 1.13 (-74.59%) | 4.43 (134.72%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.34 (-64.49%) | 0.97 (-75.39%) | 3.92 (-43.74%) | 6.98 (713.05%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0.00%) | -1 (0.00%) | -1 (66.67%) | -3 (-200.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.27 (4.08%) | -1.32 (7.34%) | -1.43 (45.19%) | -2.61 (-98.40%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 0.15 (-58.17%) | 0.36 (-78.19%) | 1.66 (-39.69%) | 2.74 (4255.56%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$10,637,000 (50.89%) | -$21,660,000 (45.53%) | -$39,765,000 (-5.45%) | -$37,710,000 (-1563.43%) |
Enterprise Value (EV) | $31,630,007 (-20.47%) | $39,769,995 (-30.02%) | $56,832,859 (-76.59%) | $242,744,906 (256.95%) |
Earnings Before Tax (EBT) | -$25,126,000 (16.66%) | -$30,150,000 (24.16%) | -$39,754,000 (57.28%) | -$93,063,000 (-79.74%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$24,891,000 (17.10%) | -$30,025,000 (24.47%) | -$39,750,000 (57.28%) | -$93,043,000 (-79.90%) |
Invested Capital | -$13,078,000 (-82.48%) | -$7,167,000 (-1120.94%) | $702,000 (111.18%) | -$6,281,000 (85.82%) |
Working Capital | -$18,561,000 (-52.59%) | -$12,164,000 (-219.14%) | $10,210,000 (-50.89%) | $20,791,000 (148.09%) |
Tangible Asset Value | $3,651,000 (-50.09%) | $7,315,000 (-71.66%) | $25,816,000 (-21.12%) | $32,729,000 (1012.79%) |
Market Capitalization | $26,607,007 (-31.08%) | $38,602,995 (-48.59%) | $75,081,859 (-73.29%) | $281,113,416 (328.57%) |
Average Equity | -$18,876,250 (-258.83%) | -$5,260,500 (-125.90%) | $20,308,000 (2082.57%) | -$1,024,326 (87.65%) |
Average Assets | $4,291,250 (-72.32%) | $15,503,500 (-51.04%) | $31,668,500 (15.06%) | $27,524,550 (413.47%) |
Invested Capital Average | -$11,299,000 (-106.35%) | -$5,475,750 (-175.37%) | -$1,988,500 (91.52%) | -$23,455,276 (-371.18%) |
Shares | 12,094,094 (44.12%) | 8,391,955 (24.07%) | 6,764,131 (15.02%) | 5,881,034 (2087.69%) |
